Asseco: M&A Strategy & Pricing Power
Former Healthcare Director at Asseco Poland
inpractise.com/articles/asseco-manda-strategy-and-pricing-power
Former Healthcare Director at Asseco Poland
Interview Transcript
This is a snippet of the transcript, sign up to read more.
The forward or backward? Could you clarify what you mean by that?
I'm referring to the fact that Asseco, for roughly the past 10 years, has primarily been a platform for acquiring new companies rather than developing their own solutions from scratch. They excel at maintaining their position and are adept at purchasing new companies to expand their portfolio. However, they are not as proficient in developing and broadening their product portfolio. They do not invest heavily in research and development, but rather focus on maintaining their area of expertise or acquiring new companies.
This is a snippet of the transcript, sign up to read more.
Why were they unable to raise prices back in 2012?
As I mentioned earlier, the barriers to entry are quite high. So, it's really difficult to replace ecosystems if they are already implemented. It's hard to replace them and they're quite good, I believe. That's why.
This is a snippet of the transcript, sign up to read more.
Why were they unable to raise prices back in 2012?
Especially in the health sector, there is significantly more money now. Hospitals and other practices are able to pay much more than they could eight or 10 years ago. They are able to raise prices, at least in the health sector, but probably also in others.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.